Skip to main contentAI and Advanced
/
JUBLINGREA · NSEBSE SENSEX77,520.04+0.20%BSE |
NIFTY 5024,247.2+0.12%NSE |
NIFTY BANK57,441.85-0.15%NSE |
NIFTY IT30,567.85-0.09%NSE |
NIFTY AUTO29,130.15+0.10%NSE |
NIFTY FMCG47,520.7-0.01%NSE |
NIFTY PHARMA26,457.9+0.45%NSE |
NIFTY 50023,541.3+0.13%NSE |
JU
NSE · Equity shares · Chemical Manufacturing-5.00 · -0.70%
Jubilant Ingrevia JUBLINGREA
NSE:INR 711
BSE:INR 755
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for JUBLINGREA
Analysis, reports, chat and Advanced access use the same ShareKeyX account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 716
Day rangeINR 694.5 — INR 726.95
52-week rangeINR 537.3 — INR 795
Volume5.68 L
Market cap12,093.17
P/E31.14
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)4,388.07
Net Income (INR Cr)277.9
Rev Growth (5 Year %)45.02
EPS Growth (5 Year %)38.68
P/E Ratio31.14
EPS18.17
Research path: Interpret Jubilant Ingrevia's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
JUBLINGREAJubilant Ingrevia1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 5,483.73 | 5,031.77 | 4,731.89 |
| Accumulated Depreciation Total | -1,149.23 | -1,007.6 | -880.71 |
| Other Liabilities Total | 194.07 | 110.31 | 64.81 |
| Accrued Expenses | 37.31 | 28.23 | 12.76 |
| Long Term Debt | 322.11 | 363.21 | 425.57 |
| Common Stock Total | 15.77 | 15.81 | 15.8 |
| Other Equity Total | 21.91 | 1.62 | -2.39 |
| Other Current Assets Total | 2.24 | 30.12 | 10.24 |
| Prepaid Expenses | 14.53 | 15.45 | 17.1 |
| Total Assets | 5,483.73 | 5,031.77 | 4,731.89 |
| Current Portof LT Debt/Capital Leases | 120.3 | 91.56 | 27.3 |
| Additional Paid-In Capital | 571.32 | 571.32 | 571.32 |
| Cash | 188.47 | 69.35 | 51.55 |
| Total Equity | 3,126.22 | 2,927.08 | 2,737.47 |
| Long Term Investments | 34.75 | 20.51 | 15.49 |
| Retained Earnings(Accumulated Deficit) | 2,598.36 | 2,392 | 2,212.6 |
| Treasury Stock-Common | -81.15 | -53.68 | -59.86 |
| Total Common Shares Outstanding | 15.77 | 15.81 | 15.8 |
| Property/Plant/Equipment Total-Gross | 4,451.59 | 4,090.57 | 3,730.34 |
| Tangible Book Valueper Share Common Eq | 196 | 183.64 | 171.97 |
| Goodwill Net | 6.13 | Not available | Not available |
| Total Liabilities | 2,357.51 | 2,104.69 | 1,994.42 |
| Total Debt | 791.81 | 763.78 | 740.24 |
| Short Term Investments | 7.06 | 20.04 | 8.44 |
| Cashand Short Term Investments | 195.54 | 89.39 | 87.22 |
| Total Receivables Net | 930.57 | 745.63 | 700.54 |
| Notes Payable/Short Term Debt | 341.77 | 303.95 | 283 |
| Deferred Income Tax | 241.99 | 225.11 | 213.58 |
| Accounts Receivable-Trade Net | 782.54 | 607.13 | 571.97 |
| Property/Plant/Equipment Total-Net | 3,302.35 | 3,082.97 | 2,849.63 |
| Total Current Liabilities | 1,591.71 | 1,401 | 1,286.08 |
| Total Inventory | 903.5 | 972.64 | 964.81 |
| Accounts Payable | 940.65 | 814.93 | 766.67 |
| Other Currentliabilities Total | 151.69 | 162.33 | 196.36 |
| Total Long Term Debt | 329.74 | 368.27 | 429.95 |
| Intangibles Net | 28.89 | 23.18 | 20.43 |
| Other Long Term Assets Total | 41.11 | 35.35 | 36.36 |
| Note Receivable-Long Term | 24.13 | 16.53 | 30.07 |
| Total Current Assets | 2,046.37 | 1,853.23 | 1,779.9 |
| Capital Lease Obligations | 7.63 | 5.06 | 4.38 |
| Cash Equivalents | Not available | 0 | 27.23 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %7.34
Margins
Operating Margin 12m9.14
Operating Margin 5y Avg9.99
Net Profit Margin 12m6.64
Net Profit Margin 5y6.67
Yield
Dividend Yield %0.67
Valuation
Price to Sale Ratio2.76
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk37.21
Analyst consensus
ConsensusStrong Buy
Consensus score1.50
Analyst opinions6
Strong Sell count0
Sell count0
Hold count1
Buy count1
Strong Buy count4
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,749 | 2.64 L | 58.09 | — |
| Solar Industries India | INR 18,560 | 1.68 L | 99.61 | — |
| Pidilite Industries | INR 1,671 | 1.70 L | 64.76 | — |
| SRF | INR 2,626 | 77,841.16 | 44.57 | — |
| Linde India | INR 7,105 | 61,033.66 | 110.53 | — |
Shareholding
Ownership
- Promoter
- 45.22%
- FII
- 6.49%
- MF
- 22.39%
- Other
- 25.90%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Buy, Sell Or Hold: Titan, VA Tech Wabag, Eternal, Patanjali Foods, BHEL, Jubilant Ingrevia — Ask Profit - NDTV ProfitMarket news · 21 Jul 2026, 9:48 am
Buy, Sell Or Hold: Titan, VA Tech Wabag, Eternal, Patanjali Foods, BHEL, Jubilant Ingrevia — Ask Profit NDTV Profit
Jubilant Ingrevia to host Q1FY27 earnings call on July 23 - scanx.tradeMarket news · 13 Jul 2026, 6:06 pm
Jubilant Ingrevia to host Q1FY27 earnings call on July 23 scanx.trade
Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz - Indian Chemical NewsMarket news · 9 Jul 2026, 6:33 pm
Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz Indian Chemical News
Stocks to Buy: 5 Stocks That Can Deliver Returns of Up to 44%; Do You Own Any? - Trade BrainsMarket news · 5 Jul 2026, 7:00 pm
Stocks to Buy: 5 Stocks That Can Deliver Returns of Up to 44%; Do You Own Any? Trade Brains
Jubilant Ingrevia - Positive Breakout: These 14 stocks cross above their 200 DMAs - The Economic TimesMarket news · 3 Jul 2026, 12:30 pm
Jubilant Ingrevia - Positive Breakout: These 14 stocks cross above their 200 DMAs The Economic Times
Jubilant Ingrevia Shares In Focus: Anand Rathi Bets On Earnings Inflection — Buy, Sell or Hold? - NDTV ProfitMarket news · 3 Jul 2026, 9:13 am
Jubilant Ingrevia Shares In Focus: Anand Rathi Bets On Earnings Inflection — Buy, Sell or Hold? NDTV Profit
Corporate actions
Events
- annual General MeetingAGM
- dividendRs.2.5000 per share(250%)Final Dividend
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
- dividendRs.2.5000 per share(250%)Interim Dividend
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
ShareKeyX Community
Discussion and sentiment for Jubilant Ingrevia
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and ShareKeyX AI.
Checking your ShareKeyX account…
Company profile
Business information
What the company does
Jubilant Ingrevia Limited is a globally integrated life sciences and specialty chemicals company. Its segments include Specialty Chemicals, Nutrition & Health Solutions and Chemical Intermediates. The Specialty chemicals segment includes bio-pyridine & bio-picolines, fine chemicals, agro chemicals, custom development and manufacturing organization, and Microbial control solutions. The Nutrition & Health solutions segment includes nutrition and health ingredients and animal and human nutrition health solutions. The Chemical intermediates segment includes Acetyls and Specialty ethanol. In agro chemicals, it offers value-added derivatives, derived from specialty building blocks, such as amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines and so on. This sub-segment includes insecticides, herbicides and fungicides. In nutrition and health ingredients, it offers products like Vitamin B3 & Picolinates (Chromium & Zinc) which are fully backward integrated.
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- JUBLINGREA
- BSE Code
- 543271
Questions
Stock FAQ
What is the symbol and ISIN of Jubilant Ingrevia?
Jubilant Ingrevia has the symbol JUBLINGREA and ISIN - INE0BY001018.
What is the current price of Jubilant Ingrevia?
Jubilant Ingrevia is currently trading at INR 711.00.
What are the year high and year low of Jubilant Ingrevia?
Jubilant Ingrevia has a year high of INR 795.00 and a year low of INR 537.30.
What is the market capitalization of Jubilant Ingrevia?
Jubilant Ingrevia has a market capitalization of INR 12,093.17 crore.
What is the P/E ratio of Jubilant Ingrevia?
Jubilant Ingrevia has a P/E ratio of 31.14.
What is the dividend yield of Jubilant Ingrevia?
Jubilant Ingrevia has a dividend yield of 0.67%.
How is the financial performance of Jubilant Ingrevia based on revenue, net income, and EPS?
Jubilant Ingrevia has revenue of INR 4,388.07 crore, net income of INR 277.90 crore, and EPS of INR 20.01.
What is the book value of Jubilant Ingrevia?
Jubilant Ingrevia has a book value of NA.
What is the debt-to-equity ratio of Jubilant Ingrevia?
Jubilant Ingrevia has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Jubilant Ingrevia?
Jubilant Ingrevia has a price-to-book ratio of NA and a price-to-sales ratio of 2.76.
Corporate-action adjustment is provider-defined. ShareKeyX research and computed indicators are not investment advice.